We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

How unSwiss

30 July 2007 By Robert Cyran

The Swiss group s decision to go hostile with a $2.6bn offer for Ventana appears odd. It has itself been hounded by an unwanted suitor. And Roche isn t promising cost cuts, so its return may be miserly. It may also have to pay more. But the deal could be canny nonetheless.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)